141 related articles for article (PubMed ID: 20809989)
21. CRP levels are higher in patients with ST elevation than non-ST elevation acute coronary syndrome.
Habib SS; Kurdi MI; Al Aseri Z; Suriya MO
Arq Bras Cardiol; 2011 Jan; 96(1):13-7. PubMed ID: 21152699
[TBL] [Abstract][Full Text] [Related]
22. Effect of a single high loading dose of rosuvastatin on percutaneous coronary intervention for acute coronary syndromes.
Wang Z; Dai H; Xing M; Yu Z; Lin X; Wang S; Zhang J; Hou F; Ma Y; Ren Y; Tan K; Wang Y; Ge Z
J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):327-33. PubMed ID: 23364255
[TBL] [Abstract][Full Text] [Related]
23. Sustained prognostic implications of newly detected glucose abnormalities in patients with acute myocardial infarction: long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohort.
Ritsinger V; Tanoglidi E; Malmberg K; Näsman P; Rydén L; Tenerz Å; Norhammar A
Diab Vasc Dis Res; 2015 Jan; 12(1):23-32. PubMed ID: 25311248
[TBL] [Abstract][Full Text] [Related]
24. High-sensitivity C-reactive protein and long term reperfusion success of primary percutaneous intervention in ST-elevation myocardial infarction.
Groot HE; Karper JC; Lipsic E; van Veldhuisen DJ; van der Horst ICC; van der Harst P
Int J Cardiol; 2017 Dec; 248():51-56. PubMed ID: 28826799
[TBL] [Abstract][Full Text] [Related]
25. Copeptin in patients with acute myocardial infarction and newly detected glucose abnormalities - A marker of increased stress susceptibility? A report from the Glucose in Acute Myocardial Infarction cohort.
Smaradottir MI; Ritsinger V; Gyberg V; Norhammar A; Näsman P; Mellbin LG
Diab Vasc Dis Res; 2017 Mar; 14(2):69-76. PubMed ID: 28118730
[TBL] [Abstract][Full Text] [Related]
26. Inflammatory markers in women with a recent history of gestational diabetes mellitus.
Di Benedetto A; Russo GT; Corrado F; Di Cesare E; Alessi E; Nicocia G; D'Anna R; Cucinotta D
J Endocrinol Invest; 2005 Jan; 28(1):34-8. PubMed ID: 15816369
[TBL] [Abstract][Full Text] [Related]
27. Changes in BNP, hs-CRP and TIMI risk index with addition of tirofiban during primary percutaneous coronary intervention for acute STEMI: a prospective observational cohort study.
Kurt IH; Demirkol S; Ünal I; Batur MK
Anadolu Kardiyol Derg; 2012 Mar; 12(2):107-14. PubMed ID: 22281789
[TBL] [Abstract][Full Text] [Related]
28. The influence of thrombolytic therapy on C-reactive protein in ST-segment elevation acute myocardial infarction.
Tsakiris AK; Marnelos PG; Nearchou NS; Papadakis JE; Karatzis EN; Skoufas PD
Hellenic J Cardiol; 2006; 47(4):218-22. PubMed ID: 16897925
[TBL] [Abstract][Full Text] [Related]
29. Factors associated with C-reactive protein at the early stage of acute myocardial infarction in men.
Piestrzeniewicz K; Łuczak K; Goch JH
Cardiol J; 2009; 16(1):36-42. PubMed ID: 19130414
[TBL] [Abstract][Full Text] [Related]
30. Fasting plasma leptin, tumor necrosis factor-alpha receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women: impact on cardiovascular mortality.
Piemonti L; Calori G; Mercalli A; Lattuada G; Monti P; Garancini MP; Costantino F; Ruotolo G; Luzi L; Perseghin G
Diabetes Care; 2003 Oct; 26(10):2883-9. PubMed ID: 14514596
[TBL] [Abstract][Full Text] [Related]
31. Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis.
Deo R; Khera A; McGuire DK; Murphy SA; Meo Neto Jde P; Morrow DA; de Lemos JA
J Am Coll Cardiol; 2004 Nov; 44(9):1812-8. PubMed ID: 15519012
[TBL] [Abstract][Full Text] [Related]
32. High cortisol levels in hyperglycaemic myocardial infarct patients signify stress hyperglycaemia and predict subsequent normalization of glucose tolerance.
Carmen Wong KY; Wong V; Ho JT; Torpy DJ; McLean M; Cheung NW
Clin Endocrinol (Oxf); 2010 Feb; 72(2):189-95. PubMed ID: 19549250
[TBL] [Abstract][Full Text] [Related]
33. What level of hyperglycaemia on admission indicates a poor prognosis in patients with myocardial infarction treated invasively?
Tomaszuk Kazberuk A; Kożuch M; Małyszko J; Bachórzewska Gajewska H; Dobrzycki S; Kosacka U; Musiał WJ
Kardiol Pol; 2012; 70(6):564-72. PubMed ID: 22718372
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of different serum biomarkers for left ventricular remodelling after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
Urbano-Moral JA; Lopez-Haldon JE; Fernandez M; Mancha F; Sanchez A; Rodriguez-Puras MJ; Villa M; Lopez-Pardo F; Diaz de la Llera L; Valle JI; Martinez A
Heart; 2012 Aug; 98(15):1153-9. PubMed ID: 22572051
[TBL] [Abstract][Full Text] [Related]
35. Pentraxin 3 in primary percutaneous coronary intervention for ST elevation myocardial infarction is associated with early irreversible myocardial damage : Kinetic profile, relationship to interleukin 6 and infarct size.
Butt N; Bache-Mathiesen LK; Ushakova A; Nordrehaug JE; Jensen SE; Munk PS; Danchin N; Dubois-Rande JL; Hansen HS; Paganelli F; Corvoisier PL; Firat H; Erlinge D; Atar D; Larsen AI
Eur Heart J Acute Cardiovasc Care; 2020 Jun; 9(4):302-312. PubMed ID: 32403934
[TBL] [Abstract][Full Text] [Related]
36. Effects of Prolastin C (Plasma-Derived Alpha-1 Antitrypsin) on the acute inflammatory response in patients with ST-segment elevation myocardial infarction (from the VCU-alpha 1-RT pilot study).
Abbate A; Van Tassell BW; Christopher S; Abouzaki NA; Sonnino C; Oddi C; Carbone S; Melchior RD; Gambill ML; Roberts CS; Kontos MC; Peberdy MA; Toldo S; Vetrovec GW; Biondi-Zoccai G; Dinarello CA
Am J Cardiol; 2015 Jan; 115(1):8-12. PubMed ID: 25456867
[TBL] [Abstract][Full Text] [Related]
37. Newly Discovered Abnormal Glucose Tolerance in Patients With Acute Myocardial Infarction and Cardiovascular Outcomes: A Meta-analysis.
Laichuthai N; Abdul-Ghani M; Kosiborod M; Parksook WW; Kerr SJ; DeFronzo RA
Diabetes Care; 2020 Aug; 43(8):1958-1966. PubMed ID: 32669411
[TBL] [Abstract][Full Text] [Related]
38. Early prognostic usefulness of C-reactive protein added to the Thrombolysis In Myocardial Infarction risk score in acute coronary syndromes.
Foussas SG; Zairis MN; Lyras AG; Patsourakos NG; Tsirimpis VG; Katsaros K; Beldekos DJ; Handanis SM; Mytas DZ; Karidis KS; Tselioti PG; Prekates AA; Ambrose JA
Am J Cardiol; 2005 Aug; 96(4):533-7. PubMed ID: 16098307
[TBL] [Abstract][Full Text] [Related]
39. Does glucose level at hospital discharge predict one-year mortality in patients with diabetes mellitus treated with percutaneous coronary intervention for ST-segment elevation myocardial infarction?
Gasior M; Pres D; Stasik-Pres G; Lech P; Gierlotka M; Lekston A; Hawranek M; Tajstra M; Kalarus Z; Poloński L
Kardiol Pol; 2008 Jan; 66(1):1-8; discussion 9-11. PubMed ID: 18266182
[TBL] [Abstract][Full Text] [Related]
40. The relationship of plasminogen activator inhibitor-1 levels to the ST deviation pattern of acute myocardial infarction.
Rott D; Leibowitz D; Finci-Yeheskel Z; Barak V; Chajek-Shaul T; Weiss T; Levin M; Urieli-Shoval S
Cardiology; 2009; 112(1):56-9. PubMed ID: 18580060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
